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Background: Mesenteric panniculitis is a rare chronic fibrosing inflammatory disease that typically affects the
adipose tissue and mesentery of the small intestine but may also affect the mesosigmoid and the mesocolon. The
pathology of this disease remains unclear despite association with some malignancies or inflammatory disorders.
We report a case of mesocolic panniculitis and a literature review of its clinical presentation, imaging findings,
associated conditions and treatment options.
Case presentation: A 64 year-old Caucasian man was admitted to the gastroenterology department for severe
weakness, left lower quadrant abdominal pain, weight loss and diarrhoea. Physical examination revealed a palpable
firm mass occupying the entire left part of the abdomen. Abdominal CT-scan showed fatty infiltration of the
mesosigmoid and left mesocolic fat which was strongly suggestive of panniculitis. Laparoscopic surgery revealed an
inflamed and edematous mesocolon and mesosigmoid; the sigmoid mucosa appeared petechial which was
suggestive of venous ischemia. Histological examination of surgical biopsies revealed mesocolic panniculitis.
Despite exhaustive investigation, no associated conditions were found and the cause was classified as idiopathic.
Surprisingly, the patient clinically improved without therapeutic intervention other than supportive care.
Conclusion: Although mesenteric panniculitis is most often a radiographic diagnosis without clinical
symptomatology, it can also present with significant general status alteration. We report a case of mesocolic
panniculitis complicated by development of an inflammatory mass associated with ischemic colitis. Mesenteric
panniculitis is a difficult diagnosis to make which typically requires histologic confirmation. The overall prognosis is
good with supportive treatment.
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Mesenteric panniculitis (MP) is a benign fibro-inflamma-
tory process involving adipose tissue of the mesentery
which is characterized by the presence of fat necrosis,
chronic inflammation and fibrosis. This term is also im-
properly used to characterize the involvement of the
mesosigmoid and the mesocolon, peripancreatic and
omental fat and less frequently retroperitoneal or pelvic
fat. We report here an unusual case of MP located in the
mesentery of the sigmoid and left colon presenting with
ischemic colitis. This rare observation of mesocolic* Correspondence: aurelie.DAUMAS@ap-hm.fr
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reproduction in any medium, provided the orpanniculitis (MCP) was notable for the reversible ischemic
colitis and abdominal pseudotumoral mass related to this
condition. Here we highlight the differential diagnosis of
this rare disease and review the published literature.
Case presentation
A 64 year-old Caucasian man was admitted to the
gastroenterology department for severe general weak-
ness, left lower quadrant abdominal pain, weight loss
(more than 10 % of his normal weight) and diarrhoea
for four weeks prior to admission. There was no his-
tory of melena, bloody diarrhea or fever. His past
medical history included only type 2 diabetes for
which he received oral antidiabetic agents. He had no
cardiovascular risk factors and did not consume alco-
hol. He had travelled to Tunisia one year previously.
Physical examination revealed a palpable firm massl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A and B: CT-scan showing mesocolic panniculitis.
Contrast-enhanced coronal (1A) and axial (1B) CT scan showing
mesocolic enlargement with hypervascularization (1), increased
density of the mesocolic fat (2) compared with mesenteric fat (3)
and ascites (4) suggestive of mesocolic panniculitis of the sigmoid
and the ascending colon.
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evidence of bowel obstruction. Blood tests showed an
elevated C-reactive protein level (80 mg/L, normal
range< 5 mg/L) without leucocytosis and a decreased
potassium level. Hepatic and pancreatic enzyme levels
and renal function tests were normal. The hepatitis B,
C and HIV serological tests were negative. Blood and
stool bacterial cultures as well as Clostridium difficile
toxin A and B were all negative. Contrast-enhanced
thoraco-abdominal CT-scan showed a thickening of
the wall of the sigmoid and ascending colon without
contrast enhancement, an increased density of the
thickened mesosigmoid and mesocolon and ascites, all
of which suggested the diagnosis of MCP (Figures 1A
and 1B). The intra-abdominal vessels were patent on
vascular contrast CT-scan findings. Complete ileo-col-
onoscopy revealed nonspecific inflammatory changes
of the sigmoid and the ascending colon. Histological
analysis of multiple colonic biopsy specimens showed
changes compatible with ischemic colitis. Analysis of
ascitic fluid revealed chylous ascites without malig-
nant cells. Tests for Mycobacterium tuberculosis in-
fection in cultures of sputum, ascites, blood and stool
were negative. Tumor markers were all in the normal
biological range and a search for an underlying auto-
immune disease was negative. Trophyrema Whipplei
PCR analysis performed on blood, saliva and stools
was negative. Serum immunoglobulins (Ig) levels and
including IgG4 subclass level were in the normal
range.
To definitely eliminate infectious or neoplastic disor-
ders, a laparoscopic surgery was performed. The mesosig-
moid and mesocolon were markedly thickened and
retractile. The normal architecture was lost and was
replaced with an irregular nodular mass which was diffi-
cult to move. The adjacent bowel wall was thickened,
edematous and congested, with a petechial aspect. There
was a moderate amount of serous ascites in the peritoneal
cavity. No neoplasia, diverticula, abscesses or enlarged
lymph nodes were identified. Histological examination of
surgical mesocolon biopsies showed scattered areas of
steatonecrosis with lipid-laden macrophages, lymphocytes
and congested capillaries (Figure 2A, 2B and 2C). There
were no granulomas, vasculitis or malignancy. All PCR
and cultures for bacteria, mycobacteria, fungi and Whip-
ple’s disease were negative. With only supportive care and
without the administration of immunosuppressive therap-
ies, the diarrhea resolved and the patient began to gain
weight, with overall symptomatic improvement. After one
year of follow-up, the patient remained in good health and
the abdominal mass decreased in size. Abdominal CT-
scan performed one year after the diagnosis confirmed the
decrease in size of the MCP and the disappearance of asci-
tes (Figure 3).
Figure 2 A, B and C: Histological sections of mesocolic panniculitis. Microscopic sections 2A (HES × 0.6) and 2 C (HES × 10) showing fibrous
septa. Microscopic section 2B (HES × 10) showing small lymphocytes around capillaries and focal steato-necrosis with lipid-laden macrophages.
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MP is a benign, tumor-like mesenteric lesion, formed as
result of chronic inflammation of adipose tissue; the eti-
ology is unknown. In the literature, the disease is named
with a number of synonyms: mesenteric lipodystrophy
and sclerosing or retractile mesenteritis, each of which is a
histologic variant based on the relative amounts of inflam-
mation, fat necrosis and fibrosis [1,2]. While a large series
of cases of small-bowel MP has been reported [1,3-14],
this process rarely involves the mesentery of the large in-
testine, as was observed in this case.
MP has a slight male predominance and commonly
occurs in late adulthood [1,3,4]. The symptoms of the dis-
ease are varied, and mostly include intermittent abdominal
pain (34.6%), presence of abdominal mass (30.8%), nausea/
vomiting, weight loss, bowel habit changes, with or with-
out fever [1,2,11,12,15,16]. In the study by Akram et al. [4],
common symptoms included abdominal pain in 70% of
cases, diarrhoea in 25% and weight loss in 23%. Symptoms
associated with MP can be caused by direct mechanical
effects of the abdominal mass encasing the bowel, blood
vessels and lymphatics, which can result in partial bowelFigure 3 CT-scan findings of mesocolic panniculitis one year
later. Axial contrast-enhanced abdominal CT scan performed one
year later showed significant improvement in the radiologic
appearance of the mass with regression in size and disappearance
of inflammatory signs in comparison to the first study.obstruction [8], ischemia [6] or chylous ascites [17]. As re-
cently reported by Van lingen et al. [14], MCP should be
considered as a possible cause of unexplained colitis but
can also manifest as ischemic colitis. The mechanism of is-
chemic colitis is thought to be secondary to venous insuffi-
ciency as opposed to arterial ischemia as evidenced by the
absence of thrombosis of mesenteric arteries [13]. We
hypothesize that severe edema of the mesocolon and
mesosigmoid related to MCP induced venous ischemia
which caused ischemia of the sigmoid mucosa. In the art-
icle by Akram et al. [4], 14% of MP patients were found to
have chylous ascites, as was also the case in our observa-
tion. The reported clinical presentation of MP of the small
intestinal mesentery or the large intestine is not signifi-
cantly different. Generalized weakness with weight loss
and severe bowel dysfunction are symptoms described in
both [8,9]. Usually, the diagnosis of MP is made after sev-
eral months’ history of recurrent abdominal pain, continu-
ing weight loss, altered bowel habits and the presence of a
palpable abdominal mass [11,15,16]. However, it is import-
ant to recall that most cases of MP (up to 92% in the study
by Daskalogiannaki et al. [5]) are asymptomatic and are in-
cidentally detected on abdominal CT performed for unre-
lated conditions.
Abdominal CT and magnetic resonance imaging
(MRI) play important roles in suggesting the accurate
diagnosis and can be used to distinguish MP
from other diseases with similar imaging features
such as carcinomatosis, carcinoid tumor, lymphoma
or desmoid tumor. The “fat ring sign” (preservation
of the densitometric values of fat near the mesenteric
vessels) and the finding of “tumor pseudocapsule”
(hyper-attenuated stripe partly surrounding the mass)
are considered to be suggestive of mesenteric in-
volvement [18]. However, in some cases, the differen-
tial diagnosis (Lymphoma / Carcinoid tumors /
Desmoid tumors / Carcinomatosis / Peritoneal meso-
thelioma / Retroperitoneal sarcoma / Amyloidosis /
IgG4-related retroperitoneal fibrosis / Infectious dis-
eases (including tuberculosis, histoplasmosis and
Whipple’s disease) / Reaction to adjacent or chronic
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cannot be narrowed by imaging alone and biopsy
with histological analysis is required.
A recent study by Zissin et al. [19] suggested that posi-
tron emission tomography (PET) with 18 FDG may be
used to differentiate between benign and neoplastic pro-
cesses of the mesentery. According to the authors, PET
can be used to correctly exclude mesenteric tumor in-
volvement when no FDG uptake was observed asso-
ciated with typical CT features of MP. However, a recent
case report [17] described a patient with symptoms and
CT findings of MP and a negative uptake of FDG on
PET, who was subsequently found to have a lymphoma
on biopsy.
Thus, a biopsy should be performed in symptomatic
patients to confirm the diagnosis of MP, because imaging
specificity is limited since a broad differential diagnosis
exists for mass lesions of the mesentery, particularly
mesenteric tumour involvement [5].
The pathological mechanism of MP is not clearly
known but would appear to involve a nonspecific re-
sponse to a wide variety of stimuli. Daskalogiannaki
et al. [5] reported the co-existence of MP and various
neoplastic diseases not involving the mesentery in up to
69% of patients with MP, most commonly urogenital
malignancies and digestive carcinoma or lymphoma but
also extra-abdominal malignancies such as lung and
breast carcinoma. Association of MP and malignancy
was previously indicated in the literature [1,9,20-23] with
30% of patients with MP having an underlying malig-
nancy such as lymphoma, for example in 8/53 patients
(4.24%) [22]. The pathogenic link between MP and ma-
lignant disease remained unclear and a possible paraneo-
plastic response was suggested [5,21]. Besides neoplastic
disorders, Emory et al. [1] reported a series of MP in
which 4.76% of patients had a history of abdominal
trauma or surgery, suggesting an inflammatory post-
traumatic fat response [24]. Furthermore, the disease
was also related to other factors such as infectious [25]
and autoimmune diseases [5], vasculitis [20], vascular in-
sufficiency, cirrhosis, peptic ulcer, pancreatitis or abdom-
inal aortic aneurysm [5]. Finally, MP can occur without
pre-existing or co-existing disease and can be classified
as idiopathic, as was the case in our observation.
MP has been included in the field of fibrotic disorders
such as retroperitoneal fibrosis, sclerosing cholangitis,
Riedel’s thyroiditis and orbital pseudo tumour [11]. The
pathogenesis of these fibrotic disorders may be related
as they share common histological features and may
have both elevated serum IgG4 levels and IgG4-produ-
cing plasma cell expansion in affected organs with fi-
brotic or sclerotic changes [26]. In our case, the patient
did not have elevated serum levels of IgG4. IgG4-related
disease is a systemic syndrome classically considered asa distinct entity belonging to the differential diagnosis of
MP. However, they can sometimes mimic one other.
Both diseases rarely co-exist as evidenced by two recent
Japanese cases reporting IgG4-related sclerosing mesen-
teritis [27,28]. Moreover, a recent review on the subject
proposes adding sclerosing mesenteritis to the list of dis-
eases associated with IgG4 disorders [29]. Further stud-
ies will be required to confirm such an association.
Several therapies have been proposed to treat MP but
no consensus has been established since no one therapy
has been shown to be superior to the others. Treatment
may include steroids [4,12,16,30,31], thalidomide, cyclo-
phosphamide [32], progesterone [33], colchicine [12],
azathioprine [16,30,31], tamoxifen [4,16,31], antibiotics,
or radiotherapy.
The surgical approach should be limited to biopsy of
the mass; resection or bypass procedures are proposed
only in cases of bowel obstruction or perforation [12].
Although Adachi et al. [10] found that MP of the colon
seems to be more progressive with surgical treatment
required more often than MP of the small intestine, our
patient did not require surgery and had spontaneous
improvement.
MP is a rare entity that occurs independently or in as-
sociation with other disorders. This process mainly
affects the mesentery of the small intestine but involve-
ment of the colon is not uncommon. Diagnosis is a chal-
lenge despite the help of imaging tools, and histological
analysis is necessary in some symptomatic cases in order
to rule out treatable alternate etiologies. Overall the
prognosis is usually good with supportive treatment,
even in symptomatic cases like the one reported here.
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